Insomnia is a classification of sleep disorders in which a person has trouble falling asleep, staying asleep or waking up too early. These disorders may also be defined by an overall poor quality of sleep. Insomnia is the most commonly reported sleep disorder. About 30 percent of adults have symptoms of insomnia. On average, most adults need seven to eight hours of sleep each night to feel alert and well-rested.
UPDATED Public Health Alert: Counterfeit Alli containing sibutramine – The U.S. Food and Drug Administration (FDA) is updating its warning to the public about a counterfeit version of Alli 60 mg capsules (120 count refill pack) being sold over the internet, particularly at online auction sites.
FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis – The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS).
Study shows that sleep disturbances improve after retirement — This study is the first to examine the trajectories in sleep disturbances before and after retirement over an extended time window. – The retirement is followed by a sharp decrease in the prevalence of sleep disturbances, revealed by researchers. This general improvement in sleep is likely to result from the removal of work-related demands and stress rather than from actual health benefits of retirement.
Internet-Based Intervention May Improve Insomnia — Participants who received the Internet intervention for insomnia significantly improved their sleep. – The Internet appears to have considerable potential in delivering a structured behavioral program for insomnia. An online insomnia intervention based on established face-to-face cognitive behavioral therapy techniques appears to improve patients’ sleep.
Snoring pregnant women at higher risk for gestational diabetes – If you are pregnant and your mate complains your frequent snoring is rattling the bedroom windows, you may have bigger problems than an annoyed, sleep-deprived partner.
Kriya Yoga Meditation may be an effective treatment for insomnia – Meditation may be an effective behavioral intervention in the treatment of insomnia, according to a research presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.
Cognitive behavioral therapy is an effective treatment for chronic insomnia – A majority of people experiencing chronic insomnia can experience a normalization of sleep parameters through the use of cognitive behavioral therapy for insomnia (CBT-I), according to a research abstract presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.
Online cognitive behavioral therapy is effective in treating chronic insomnia – A study in the June 1 issue of the journal SLEEP demonstrates that online cognitive behavioral therapy (CBT) for chronic insomnia significantly improves insomnia severity, daytime fatigue, and sleep quality. Online treatment also reduces erroneous beliefs about sleep and pre-sleep mental arousal.
The antidepressant citalopram does not appear to reduce the occurrence of repetitive behaviors in children and teens with autism spectrum disorders. – Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers.
Combination Therapy Appears Helpful for Short-Term Treatment of Insomnia; Cognitive Behavior Therapy May Be Better for Long-Term – For patients with persistent insomnia, a combination of cognitive behavior therapy (CBT) and the medication zolpidem for 6 weeks was associated with modest improvement in sleep, although for a longer treatment period CBT alone was more beneficial, according to a study in the May 20 issue of JAMA.
Chronic insomnia with short sleep duration is a significant risk factor for hypertension. Findings suggest that chronic insomnia is a major public health concern, and its diagnosis and appropriate treatment should become the target of public health policy. – Chronic insomnia with objectively measured short sleep time is an independent and clinically significant risk factor for hypertension.
Insomnia often appears to be a persistent condition – About three-fourths of individuals with insomnia report experiencing the condition for at least one year and almost half experience it for three years.
